Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl added to lidocaine for inferior alveolar nerve block in painful mandibular molars
IRCT20191114045442N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in irreversible pulpitis comparing Lidocaine + epinephrine + fentanyl with Lidocaine + epinephrine + sterile distilled water (2 arms). Primary endpoint: Pain. Started Jan 2020; status: completed.
02
Drugs
fentanyllidocaineepinephrine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20191114045442N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191114045442N1.